Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of Oral MRT-2359 With Apalutamide in Prostate CancerGenital Diseases, Male Urogenital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, adenocarcinoma, carcinoma, epithelial neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorderRecruitingPhase 22026-10-08NCT07745361

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Monte Rosa Therapeutics, Inc3

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Henry FordNoviUnited States1
Hoag Memorial Hospital PresbyterianNewport BeachUnited States66
Kansas University Cancer CenterKansas CityUnited States2
Lancaster UrologyLancasterUnited States1
Levine Cancer InstituteCharlotteUnited States110
Rocky Mountain Cancer CenterColorado SpringsUnited States2
Sarah Cannon Research InstituteNashvilleUnited States119
START Los AngelesLos AngelesUnited States14
START Mountain RegionWest Valley CityUnited States46
START New JerseyEast BrunswickUnited States16
University of Maryland Greenebaum Cancer CenterBaltimoreUnited States20
University of Washington Medical CenterSeattleUnited States104
Virginia Cancer SpecialistsFairfaxUnited States109
XCancer OmahaOmahaUnited States5